DDOG vs PFE: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Pfizer Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Datadog, Inc. ยท Technology
$256.92
+28.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
DDOG has more upside to fair value
(+28.7%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
DDOG |
PFE |
| Current Price |
$256.92 |
$27.64 |
| Fair Value Estimate |
$330.72 |
$30.94 |
| Upside to Fair Value |
+28.7%
|
+12.0%
|
| Market Cap |
$91.5B |
$157.5B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
350.6x
|
17.4x
|
| Price / Sales |
23.1x
|
2.5x
|
| Price / FCF |
78.9x
|
14.3x
|
| Revenue Growth YoY |
+35.6%
|
+2.6%
|
| Gross Margin |
79.5%
|
71.3%
|
| Operating Margin |
0.4%
|
25.1%
|
| Return on Equity |
4.6%
|
4.9%
|
| Dividend Yield |
0% |
6.22% |
| FCF Yield |
1.27%
|
6.97%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Datadog is a cloud observability platform that unifies infrastructure monitoring, application performance management, log management, security, and incident response into a single SaaS offering used by developers and IT operations teams across North America and internationally. The business quality is high on the top line: revenue grew 35.6% year over year in the most recent quarter, TTM gross maโฆ
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โฆ
Accumulation Zones
| Metric |
DDOG |
PFE |
| Zone Low |
$248.04 |
$23.21 |
| Zone High |
$281.11 |
$26.30 |
| In Buy Zone? |
Yes
|
No
|